Quarterly Results

SEQUENT SCIENTIFIC LTD.

NSE : SEQUENTBSE : 512529ISIN CODE : INE807F01027Industry : Pharmaceuticals & DrugsHouse : Sequent
BSE115.30-4.45 (-3.72 %)
PREV CLOSE ( ) 119.75
OPEN PRICE ( ) 120.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 98296
TODAY'S LOW / HIGH ( )114.90 123.00
52 WK LOW / HIGH ( )65.68 155.45
NSE115.50-4.3 (-3.59 %)
PREV CLOSE( ) 119.80
OPEN PRICE ( ) 119.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 115.50 (6855)
VOLUME 1589443
TODAY'S LOW / HIGH( ) 114.60 122.90
52 WK LOW / HIGH ( )65.7 155.5
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
3293.59
3459.67
3332.08
3666.68
Total Expenditure
3071.1
3308.36
3414.44
3700.36
PBIDT (Excl OI)
222.49
151.31
-82.36
-33.68
Other Income
45.18
16.48
7.93
17.37
Operating Profit
267.67
167.79
-74.42
-16.31
Interest
125.81
125.8
104.84
108.7
Exceptional Items
27.6
80.67
-235.11
-615.96
PBDT
169.46
122.66
-414.38
-740.97
Depreciation
154.55
153.6
142.41
147.05
Profit Before Tax
14.91
-30.94
-556.79
-888.02
Tax
-91.85
37.88
-209.98
36.38
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
106.76
-68.82
-346.81
-924.4
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
106.76
-68.82
-346.81
-924.4
Minority Interest
-24.08
-14.98
-1.65
-11.35
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
82.68
-83.8
-348.46
-935.75
Equity Capital
498.86
498.86
498.87
498.86
Face Value (IN RS)
2
2
2
2
Reserves
NA
NA
NA
NA
Calculated EPS
0.33
-0.33
-1.39
-3.75
Calculated EPS (Annualised)
1.32
-1.34
-5.58
-15.00
No of Public Share Holdings
117753392
117753392
117753392
117753392
% of Public Share Holdings
47.21
47.21
47.21
47.21
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
6.75
4.37
-2.47
-0.91
PBIDTM%
8.12
4.84
-2.23
-0.44
PBDTM%
5.14
3.54
-12.43
-20.20
PBTM%
0.45
-0.89
-16.70
-24.21
PATM%
3.24
-1.98
-10.40
-25.21
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.